Esg
August 27, 2025
Health Management and Viral Hepatitis in Brazil: Policies and Sustainable Development Goals in an Integrated Perspective
DOI: 10.22167/2675-6528-2025023
E&S 2025, 6: e2025023
Josué Souza Gleriano; Carlise Krein; Lucieli Dias Pedreschi Chaves
Viral hepatitis (VH) constitutes a set of infections that affect the liver, with differences in transmission routes and clinical evolution. Hepatitis A and E, transmitted via the fecal-oral route, are predominantly acute; hepatitis B, C, and D can present chronic evolution, being associated with cirrhosis and liver cancer. Prevention is based primarily on vaccination against hepatitis A and B, while hepatitis C currently has curative treatment with direct-acting antivirals (DAAs). In this context, VH constitutes a serious global public health problem, given its silent clinical evolution, which contributes to high morbidity and mortality and a significant impact on health systems[1,2]. Thus, it becomes necessary to understand how Brazilian policies dialogue with international commitments and how the Unified Health System (SUS) responds to persistent challenges.
It is estimated that more than 350 million people worldwide live with chronic hepatitis B or C, most of them undiagnosed[1]. This global scenario is also reflected in the Americas, where approximately 3.9 million have hepatitis B and 7.2 million have hepatitis C, with a highlight on the high prevalence of hepatitis B in the Amazon region of Brazil, Colombia, Peru, and Venezuela. However, the magnitude of these infections is still little recognized, mainly due to the fragility of health surveillance in Latin America and the Caribbean, evidenced by the reduced number of countries that regularly report cases [2,3].
In Brazil, the situation follows this trend, with 826,292 cases of viral hepatitis confirmed between 2000 and 2024, with a predominance of hepatitis C (41.5%) and B (36.6%). The severity of the national scenario is reinforced by the fact that hepatitis C was responsible for 75.3% of deaths from VH, followed by B (22.0%). Despite the recent reduction in hepatitis B and C detection rates, important challenges persist, such as the maintenance of high incidences in some capitals and significant regional inequality, exemplified by the concentration of 72.4% of hepatitis D cases in the North region and the predominance of hepatitis C in the Southeast[4].
In this scenario, the Unified Health System (SUS) has played a fundamental role through the National Program for the Prevention and Control of Viral Hepatitis (PNHV), established in 2002, which in recent years has particularly advanced in prevention actions through vaccination and in the publication of guidelines aimed at the decentralization of care and the organization of the service network[5]. These advances, driven by the PNHV, have gained even more visibility in the country with the creation of the “Yellow July” campaign, established by Law No. 13.802/2019, which reinforces surveillance, prevention, diagnosis, and treatment actions, while simultaneously increasing public awareness and mobilizing health services, consolidating the role of SUS in confronting VH as a chronic condition of national relevance[6].
Regarding surveillance actions, in Brazil, it is pertinent to recognize that the guidelines of the National Policy for Health Surveillance (PNVS)[7] must be understood as structuring pillars in the process of eliminating NTDs. The dependence of NTDs on timely diagnosis and systematic notification makes health surveillance essential for guiding strategic decisions, identifying inequalities, and monitoring progress [5].
In the field of prevention, the offer of vaccines against hepatitis A and B stands out. Immunization against hepatitis B, introduced in Brazil even before the creation of the SUS, represents a fundamental measure not only for preventing chronification and its complications, such as cirrhosis and hepatocellular carcinoma, but also for directly impacting the control of hepatitis D[8,9]. The incorporation of the hepatitis A vaccine into the National Immunization Program (PNI) represented a significant advance, especially in regions marked by precarious sanitary conditions[8]. However, despite the progress made, regional inequalities and failures in the homogeneity of vaccination coverage persist, pointing to a need for specific strategies aimed at populations in greater vulnerability, such as indigenous peoples, riverine communities, and residents of hard-to-reach areas[9].
In 2010, the World Health Organization (WHO) officially recognized STIs as a global public health threat. Aligned with this recognition, the United Nations (UN) Agenda 2030 establishes 17 Sustainable Development Goals (SDGs) and 169 targets to be achieved by 2030, guiding public policies, investments, and initiatives focused on the social, economic, and environmental dimensions[11]. Within this framework, SDG 3, by addressing the fight against communicable diseases, acknowledges STIs as one of the health burdens to be tackled in the global agenda. In line with this, the WHO has set ambitious targets for 2030, proposing a 90% reduction in new infections and a 65% reduction in deaths from STIs. To achieve these results, it is projected to diagnose 90% of infected people and ensure treatment for at least 80% of diagnosed cases[12].
The relevance of the SDGs for health, and in particular for tackling STIs, stems from the fact that they integrate specific goals related to universal access to health services, expanded vaccination coverage, strengthened surveillance, and the fight against communicable epidemics. In this sense, analyzing the relationship between the SDGs and the Unified Health System (SUS) allows us to understand how national guidelines align with global commitments, reinforcing the importance of governance, equity, and decentralization as strategies for achieving elimination goals.
Given the foregoing, it becomes imperative to critically reflect on and analyze public health management strategies aimed at confronting STIs in Brazil, especially in light of the international commitment to the SDGs and the persistence of profound inequalities in access to diagnosis, treatment, and comprehensive care. This scenario reinforces the need to understand the challenges of implementing public policies, incorporating innovations into services, and establishing intersectoral and regionalized actions capable of reducing inequities and expanding the reach of interventions.
Therefore, a critical reflection is proposed on alternatives that overcome historical barriers and consolidate more concrete responses from the SUS in confronting HV, taking the SDGs, intersectoral integration, and innovation in services as a reference. This analysis is based on both theoretical references and the authors’ practical experience in examining SUS management. It should be noted that, by using the SDGs as a reference[11] for priority health management strategies, it is possible to transform global goals into concrete instruments of accountability and public action, by advancing in the realization of the proposed objectives.
The articulation between the SUS and SDGs requires confirming structuring guidelines that sustain the logic of the system’s organization. From this perspective, regionalization and the conformation of Health Care Networks (RAS) allow aligning that the universality of access can guarantee the rationality of care at different levels, a fundamental condition for achieving proposed elimination goals. Integrality, by contemplating actions from promotion and prevention to rehabilitation and palliative care, broadens the correspondence that health care be continuous and centered on people’s needs[5].
It is worth considering that equity, in turn, strengthens the relationship with the goals of reducing inequalities by prioritizing populations and territories in greater vulnerability. The principle of decentralization and tripartite financing is decisive for translating global goals into policies sensitive to regional diversities, ensuring that implementation occurs in a capillary manner in municipalities.
It is worth noting that health planning for implementation in municipalities must occur through social participation, which, materialized in health councils and conferences, constitutes a unique element of the SUS in dialogue to ensure democratic governance and institutional partnerships. It is about convening those who directly experience the health issue in their territories to participate, in a legal and legitimate perspective, in the spaces for building the SUS.
This articulation between universality, equity, decentralization, tripartite financing, and social participation reveals that the governance of SUS, while engaging with regional diversities, is also anchored in democratic mechanisms of collective decision-making that are reinforced within the scope of the SDGs.
SDG 3 connects in a strategic way, as, by proposing the confrontation of transmissible diseases and recognizing HV as a public health problem, it reinforces that management should not be limited to technical or biomedical responses, but should assume political commitments that strengthen surveillance from the perspective of the integrality of care.
Addressing viral hepatitis also requires recognizing the influence of environmental and social determinants on its distribution. SDG 6, by proposing to guarantee the availability and sustainable management of water and sanitation for all, is directly related to the prevention of fecal-oral transmission routes, as in the case of hepatitis A and E, whose occurrence is strongly associated with a lack of access to drinking water, precarious basic sanitation, and unhealthy housing conditions. Thus, ensuring the achievement of this global objective also strengthens the SUS’s capacity to reduce the incidence of these diseases, as improving the environment and sanitary conditions constitutes a preventive measure as relevant as vaccination and epidemiological surveillance.
The integration between epidemiological and laboratory surveillance, with early detection capacity, expanded testing, and information systems, allows not only to measure the real burden of the disease but also to evaluate the impact of vaccination, treatment, and prevention policies. In this sense, strengthening health surveillance, associated with expanding vaccination coverage, represents an indispensable path to consolidate the role of the SUS as a protagonist in fulfilling the elimination goals defined by the WHO.
It is of utmost importance to recognize that the true rupture stems from the acknowledgment that the persistence of HVs in the territory is deeply rooted in structural inequalities, which requires incorporating SDG 10, making equity a cross-cutting axis of health management, rather than a rhetorical appendix to government plans. It is necessary to go beyond the logic of coverage and confront the inequalities that produce different times, accesses, and meanings for care, as the health system often operates under an apparent principle of universality that, in practice, does not broadly and adequately consider the structural and social differences between individuals and territories[13].
HV do not affect bodies or spaces equally, as their distribution follows patterns of social, racial, and geographical injustice. Ignoring these asymmetries means maintaining a management that reinforces the invisibility of vulnerabilities, even when testing or treatment offers are expanded[14,15].
Complementarily, SDG 11, which addresses the construction of sustainable cities and communities, dialogues with the reality of HV by exposing the territorial inequalities that affect access to diagnosis and treatment. The way urban and rural spaces are planned and inhabited reflects patterns of social, racial, and geographical injustice itself, perpetuating the vulnerability of certain population groups. Territories with poor urban infrastructure, absence of health services, precarious sanitation, and low political visibility are the most impacted by difficulties in accessing care.
As HV, understood as socially determined diseases, demand an expanded approach from health management, capable of integrating the social, economic, and political determinants that sustain their persistence. In this sense, the SDGs are configured as a strategic reference, offering an agreed governance structure that can guide health planning in a more integrated, equitable, and intersectoral manner.
It is reiterated that SDG 1, by proposing the eradication of poverty, directly dialogues within the social context in which the priority groups of NTDs are inserted, especially in underdeveloped and developing countries, where structural inequality manifests more forcefully. In these realities, poverty not only limits access to adequate food, education, sanitation, and health services, but also perpetuates cycles of vulnerability that compromise early diagnosis, timely initiation of treatment, and adherence to available therapies. Even in countries like Brazil, which have a universal public system such as the SUS, the persistence of social and territorial inequalities reveals that the elimination of NTDs cannot be achieved without addressing poverty as a structural determinant of illness.
The SUS, by structuring Primary Health Care (PHC) on territorial and community bases and through interdisciplinary action, strengthens the bond established with communities, which allows for increased vaccination coverage, intensification of health prevention and promotion actions, guarantee of timely testing, and longitudinal follow-up of people in treatment. The presence of PHC in the daily lives of the territories makes it possible to identify social and cultural barriers to care, articulating with other public policies to address the social determinants that sustain the persistence of HV.
In this organizational arrangement of the healthcare model in the SUS, the nurse’s role becomes strategic by acting as a link between direct user care and decision-making processes in Primary Healthcare, health surveillance, and the coordination of Regional Health Networks (RAS). This professional contributes to consolidating the management of programs aimed at addressing high-burden diseases[16].
When assuming local management of basic units and being present in Specialized Care Services (SAE), the nurse performs functions ranging from the organization of the work process and identification of gaps in care flows to intersectoral articulation and mediation between different levels of care. This position places them centrally in the operationalization of guidelines such as integrality, regionalization, and equity, reinforcing their role as a key player in strengthening public policies[16].
Public policies must operate based on the mapping of vulnerabilities and the listening to marginalized subjects and collectives, not just on the fulfillment of quantitative goals. For this, SDG 17 emerges as a condition of viability, by making it explicit that without collaborative governance, sustainable financing, qualified social participation, and innovation connected to the reality of the territories, there will be no elimination, only intermittent containment.
Considering that addressing NTDs must be strengthened by democratic governance, by improving health surveillance, and by expanding social participation, the relevance of SDG 16 as a guiding framework becomes evident. In the context of the SUS, incorporating this perspective means ensuring that policies and resources for NTDs are managed with transparency, effectiveness, and equity, in order to reach marginalized populations who remain outside official statistics and health actions. Thus, SDG 16 should not be seen merely as an abstract principle of social justice, but as a concrete framework for institutional strengthening and rights guarantee, an indispensable condition for advancing in the elimination of NTDs as a public health problem.
As we deepen the analysis of the relationship between the SDGs and the governance of the SUS, it becomes evident that health management must be conceived not only as a technical-administrative process, but as an ethical and political practice oriented towards the transformation of social, institutional, and territorial structures that produce and reproduce inequities. In this sense, confronting HV [Health Vulnerabilities] forcefully illustrates the limits of responses centered on immediate goals or fragmented actions, as their persistence and unequal distribution reveal historical failures in promoting equity and in the state’s capacity to guarantee comprehensive care for systematically invisibilized populations, such as indigenous people, incarcerated individuals, drug users, homeless people, riverine communities, migrants, and other groups in greater vulnerability[12,13,17].
A central point concerns the capacity of health management to implement equity as a structuring practice in decision-making. This requires mapping and addressing inequalities in access to diagnosis, treatment, and prevention of STIs[18]. The analysis of the territorial distribution of services and detection rates reveals profound disparities between regions and population groups, but it is in the persistence of barriers to access in peripheral territories and vulnerable populations that equity often remains in the realm of institutional discourse[17,19]. The production and use of data disaggregated by race/color, age group, schooling, and territory are essential to guide policies that reduce inequities and promote social justice.
Eliminating NTDs is not just a sanitary or technological task, but a civilizational imperative, which requires confronting the logic of institutional indifference and selective neglect. This implies recognizing that access to diagnosis, treatment, and comprehensive care cannot be determined by postal code (CEP) – which is often non-existent in informal and most marginalized territories and communities – by skin color, by level of education, or by belonging to stigmatized groups. Thus, reinventing health management strategies requires expanding spaces for listening and social participation, strengthening intersectorality, valuing local knowledge, and adopting an active stance against inequities. Only then will it be possible to consider the elimination of NTDs as a policy of justice and not just as an impact statistic.
Given the complexity of addressing NTDs in Brazil, especially in light of the SDGs and the principles that structure the SUS, it becomes necessary to formulate strategic questions that challenge the limits of the current management model and provoke critical reflection on its direction. In this sense, the central question arises: is there, in fact, an effective political and institutional commitment to the elimination of NTDs, or what prevails is the reproduction of formal pacts, detached from the concrete reality of the territories and the most vulnerable populations? Has public management succeeded in transforming equity into concrete practice, or does it remain trapped in the logic of superficial coverage? How to ensure that the innovation and intersectorality foreseen in the SDGs materialize in the territories where illness is a daily and invisible reality?
The answers, however, are neither simple nor ready-made. They require critical effort on the paths already taken, as there is evidence built over more than 35 years of SUS consolidation and more than 20 years of PNHV existence, which can and should be analyzed. It is in this historical, institutional, and territorial accumulation that important clues lie for the construction of alternatives aimed at the elimination of HV in the country[5].
By proposing this critical analysis of Brazil’s commitment to the elimination of HV, the objective is not to establish a single reference format for evaluation, but to offer a reflective roadmap that allows for the identification of advances, gaps, and concrete possibilities for transformation in public management aimed at the elimination of HV.
It is essential to examine whether state and municipal health plans effectively incorporate the guidelines proposed by Agenda 2030, especially concerning SDG 3. The presence of specific goals, compatible budget allocation, and monitoring mechanisms for indicators reveal whether political agreements translate into concrete action in different territories. Although the country has clinical protocols and free medicines through the SUS, the elimination of HV requires more than inputs, as it has not yet fully reached people in need of diagnosis; sustained institutional prioritization and mobilization of different management levels are necessary[5].
It is necessary to consider if and how the promises of technological innovation and intersectorality are effectively incorporated into the management of HV care. The existence of intersectoral projects that integrate health, social assistance, education, justice, civil society organizations, and social movements can indicate progress towards a more comprehensive and sustainable response. Similarly, the adoption of technologies such as rapid testing, teleconsultation, electronic health records, and regional care pathways should be analyzed for their reach in the most vulnerable territories to prevent the concentration of innovations only in large urban centers[20]. It is also fundamental to assess the degree of social participation in decisions, especially in social control spaces and in the management committees of HV policies, as an indicator of democratized management and co-responsibility in addressing the problem.
On the path to the elimination of NTDs, although the SUS has guidelines that point to integrality, intersectorality, and surveillance, institutional barriers persist that hinder the implementation of anticipatory strategies. The structures that support the current health management model remain strongly marked by fragmented practices, centered on responding to illness already established[21].
It is pertinent to analyze whether the health management model can act on the social determinants of health. Regional inequalities in care for HV reveal the insufficiency of a model that still responds more to the logic of service supply than to the analysis of the real needs of the territories, characterized not only by coverage failures, but also by the absence of territorialized planning and effective inter-federative coordination mechanisms[17].
It is therefore a matter of purposefully questioning the real conditions of innovation in health: how to ensure that technological innovation is effectively connected to the reality of the territories and populations most affected by HV? This inquiry requires going beyond the adoption of technologies in a verticalized or detached manner from the socio-epidemiological context. The effectiveness of rapid testing, telemedicine, or digital platforms depends on the incorporation of these technologies into integrated strategies, sensitive to territorial and cultural diversity[11,16].
Within the scope of the management function, it is necessary for decisions about innovation to be anchored in situational diagnoses and regional agreements, with equitable resource allocation and direct involvement of local managers. From the perspective of evidence-based practice, innovations should be selected and evaluated based on studies that demonstrate real impact on access, diagnosis time, and treatment adherence, especially among vulnerable populations. Furthermore, management must implement mechanisms for continuous monitoring and listening to users and workers, so that technologies adapt to the realities of services and territories. Without this alignment between innovation, scientific evidence, and context, there is a risk of reinforcing inequalities and even exclusion under the discourse of modernization.
The context of the elimination of STIs requires health management to move beyond the traditional focus on absolute numbers of tests or treatments performed and advance to indicators that express equity in access, such as time between diagnosis and start of treatment, reach to vulnerable populations, resolvability in primary care, and social participation in decision-making processes[18]. From this reflection, an additional challenge arises: the possibility of constructing these indicators based on evidence produced over more than two decades of STI policies in Brazil. Furthermore, ethical monitoring requires metrics that reveal not only who was attended to, but who was systematically left out, that is, that scrutinize care gaps and invisibilized populations. The challenge is to transform performance evaluation into an instrument of health justice and not just technical productivity.
As discussions on innovation, equity, and resoluteness deepen, it is essential to recognize that the limits of health management are not only technical or operational, but also ethical and political. The persistence of inequalities in addressing HV reveals that, beyond goals and indicators, there are lives that remain neglected, especially those situated at the margins of the system, geographically, socially, and symbolically. The invisibility of people who do not access diagnosis, who do not reach treatment, or are not even considered in local planning highlights a management still far from the fundamental principle of the SUS: health as a universal right and a duty of the State.
The launch of the Healthy Brazil Program: Unite to Care, through Decree No. 11.908/2024[22], represents a historic opportunity to reposition the fight against NTDs within an intersectoral social justice agenda. By recognizing NTDs as socially determined diseases, the program breaks with the fragmented tradition that restricts their approach to the biomedical and health fields and expands the scope of the response to include structural determinants such as poverty, hunger, unequal access to infrastructure, and denial of rights. However, this conceptual shift requires a radical reconfiguration of health management, which must replace the logic of verticalized tutelage with territorialized co-management models, anchored in evidence, social listening, and effective agreements among the various sectors involved.
In this sense, the guidelines of the Healthy Brazil Program guide a conceptual shift in the management model’s structure, which should move away from a focus on goals and protocols to adopt an ethical-political model, capable of articulating public policies under the logic of distributive justice and territorial equity. The emphasis on combating hunger, poverty, and expanding social protection cannot be dissociated from the urgency to overcome the invisibility of populations affected by HV, whose voices are rarely considered in decision-making processes. Similarly, the incentive for science, technology, and innovation needs to serve the lives of individuals in the territories and not just the production of data or market solutions. The proposed intersectorality cannot be reduced to cooperation protocols between ministries; it must create permanent structures for co-responsibility, cross-financing, and participatory management, especially in territories that concentrate the highest burden of preventable illness.
Despite the relevance of the inequalities pointed out throughout the text, it is worth highlighting the lack of sufficient quantification of these disparities, at the national level, in robust comparative studies between health regions specifically focused on VBDs. This gap highlights the need for investments in research that articulate epidemiological data, access indicators, and sociodemographic characteristics in a regionalized manner, allowing for a more precise evaluation of how the federative structure and the organization of the SUS influence the response to confronting VBDs in Brazil[18].
Eliminating HV, in this new horizon, is not just a matter of health, but a test of political coherence: is the State willing to face the inequalities that are produced and reproduced within its own institutional arrangements?
In this sense, it is necessary to promote a deeper reflection on the commitments that guide public health action. Within the scope of ethics, power, and accountability, central questions remain: who is responsible for people who die without a diagnosis or access to treatment, even with protocols and medications available in the SUS? How to transform health management into a practice of social justice and not just technical management of diseases? Is the health system willing to invert priorities and invest in the margins, where hepatitis still represents invisibility? These questions are essential to challenge the role of public management and reorient it towards practices committed to dignity, listening, and historical reparation of health inequities.
Given the foregoing, it is necessary to recognize social actors capable of convening managers, SUS workers, researchers, and civil society to assume an active role in building integrated, innovative responses committed to the elimination of NTDs. It should be emphasized that NTDs are not limited to meeting international goals, but involve guaranteeing the right to a dignified life, timely care, and reparation for historical inequalities that affect access to health in Brazil. To this end, it is necessary to strengthen evidence-based public management, agree on responsibilities at different levels of the system, ensure adequate funding, and foster participatory processes that give voice to territories and vulnerable populations.
Reaffirming the commitment to the elimination of HV is, therefore, reaffirming the SUS as a civilizing project, a system that not only cares but transforms realities, promotes equity, and recognizes care as an expression of an ethical, technical, and political pact with life and with the country’s economic development.
REFERENCES
[1] Organização Pan-Americana da Saúde (OPAS). 2020. Dia Mundial da Hepatite 2020: Um Futuro Livre de Hepatite. OPAS/OMS: Washington, EUA. Disponível em: https://www.paho.org/pt/noticias/28-7-2020-dia-mundial-da-hepatite-2020-um-futuro-livre-hepatite. Acesso em: 28 juln. 2025.
[2] Organização Mundial da Saúde (OMS). 2019. Hepatite B, notas descritivas. OMS: Genebra. Disponível em: https://www.who.int/es/news-room/fact-sheets/detail/hepatite-b. Acesso em: 8 jul. 2025.
[3] Gomez R.A.Z.,; Sornoza, J.L.Q.. Perfil hepático y factores de riesgo para hepatitis B en adultos de América latina. [Trabalho de Conclusão de Curso]. Universidad Estatal Del Sur De Manabí, Manabí, Equador. : Universidad Estatal Del Sur De Manabí, Equador; 2023. 72p. [citado 2025 jun 22]. Disponível em: https://repositorio.unesum.edu.ec/bitstream/53000/4945/1/Quimis%20Sornoza%20Jos%c3%a9%20Leonardo%20-%20Zavala%20G%c3%b3mez%20Roberto%20Alejandro.pdf. Acesso em: 22 jun. 2025.
[4] Ministério da Saúde (BR). Brasil. 2025. Boletim Epidemiológico – Hepatites Virais 2025. Brasília, DF. Ministério da Saúde; 2025 [citado 2025 jun 22]. Disponível em: file:///C:/Users/saude/Downloads/Boletim%20Epidemiol%C3%B3gico%20de%20Hepatites%20Virais.pdf. Acesso em: 22 jun. 2025.
[5] Gleriano, J.S.;, Chaves, L.D.P.;, Pantoja, V.J.C.;, Caminada, S. 2023. 20 Anos do Programa Nacional para a Prevenção e o Controle das Hepatites Virais: Processo Histórico e Contribuições para a Gestão. Revista de Administração. Pública. e Gest.ão Social. 2023; 15(3).
[6] Ministério da Saúde Brasil (BR). 2019. Lei n.º 13.802, de 10 de janeiro de 2019. Institui o Julho Amarelo, a ser realizado a cada ano, em todo o território nacional, no mês de julho, quando serão efetivadas ações relacionadas à luta contra as hepatites virais. Ministério da Saúde, Brasília, DF. [citado 2025 Jun 28]. Disponível em: https://www.planalto.gov.br/ccivil_03/_ato2019-2022/2019/lei/l13802.htm. Acesso em: 28 jun. 2025.
[7] Ministério da Saúde Brasil (BR). 2018. Resolução n.º 588, de 13 de agosto de 2018. Dispõe sobre a Política Nacional de Vigilância em Saúde. Ministério da Saúde, Brasília, DF. [citado 2025 Ago 22]. Disponível em: https://bvsms.saude.gov.br/bvs/saudelegis/cns/2018/res0588_13_08_2018.html. Acesso em: 22 ago. 2025.
[8] Moura, W.E.A.; Caetano, K.A.A.; Lima, J.O.R.; Campos, L.R.; Silva, G.R.C.; Moraes, J.C.; Teixeira, M.G.L.C.; Teles, S.A.; Silva, A.I.; Ramos Jr., A.N.; França, A.P.; Oliveira, A.N.M.; Boing, A.F.; Domingues, C.M.A.S.; Oliveira, C.S.; Maciel, E.L.N.; Guibu, I.A.; Barata, R.C.B.; et al. 2024. Inquérito de cobertura vacinal da hepatite A em crianças de 24 meses de idade residentes em capitais do Brasil, 2020. Epidemiologia e Serviços de Saúde. 2024; 33: e20231162. [citado 2025 Ago 22]. Disponível em: https://www.scielosp.org/article/ress/2024.v33nspe2/e20231162/pt/. Acesso em: 22 ago. 2025.
[9] Nunes, L. 2021. Panorama da Cobertura Vacinal no Brasil, 2020. Instituto de Estudos para Políticas de Saúde. São Paulo. 2021. [citado 2025 Ago 22]. Disponível em: https://ieps.org.br/wp-content/uploads/2021/05/Panorama_IEPS_01.pdf. Acesso em: 22 ago. 2025.
[10] World Health Organization. 2024. Global hepatitis report 2024: action for access in low-and middle-income countries. Geneva: WHO: Geneva. Disponível em; 2024 [cited 2025 Jun 12]. Available from: https://iris.who.int/handle/10665/376409. Acesso em: 12 jun. 2025.
[11] Nações Unidas para o Brasil. 2015. Objetivos do Desenvolvimento Sustentável. Transformando Nosso Mundo: A Agenda 2030 para o Desenvolvimento Sustentável. 2015. [citado 2025 Jun 15]. Disponível em: https://brasil.un.org/sites/default/files/2020-09/agenda2030-pt-br.pdf. Acesso em: 15 jun. 2025.
[12] Gleriano, J.S.;, Chaves, L.D.P.;, Ferreira, J.B.B. 2022. Repercussões da pandemia por Covid-19 nos serviços de referência para atenção às hepatites virais. Physis, 2022; 32(4):e320404. https://doi.org/10.1590/S0103-73312022320404.
[13] Gleriano, J.S.;, Chaves, L.D.P. 2023. Aspectos que fragilizam o acesso das pessoas com hepatites virais aos serviços de saúde. Escola Anna Nery Revista de Enfermagem. Esc. Anna Nery Rev. Enferm, 2023;27: e20220334. https://doi.org/10.1590/2177-9465-EAN-2022-0334pt
[14] Gleriano, J.S.;, Chaves, L.D.P.;, Ferreira, J.B.B. 2022. Repercussões da pandemia por Covid-19 nos serviços de referência para atenção às hepatites virais. Physis, 2022; 32(4):e320404. https://doi.org/10.1590/S0103-73312022320404.
[15] Gleriano, J.S.;, Krein, C.;, Ludwig, M.G.;, Rodrigues, W.K.A.;, Barbosa, V.O.;, Almeida, E.C.,; et alPantoja, V.J.C.; Chaves, L.D.P. O enfermeiro da atenção primária à saúde na eliminação das hepatites virais. Enferm Foco 2024; 15(Supl 2):89-96. https://doi.org/10.21675/2357-707X.2024.v15.e-202411SUPL2.
[16] Gleriano JS, Krein C, Henriques SH, Chaves LD. 2024. Eliminação das hepatites virais: o que a enfermagem brasileira pode contribuir? Enfermagem em Foco. 2024;15(Supl2): S198-203. https://doi.org/10.21675/2357-707X.2024.v15.e-202426SUPL2.
[17] Gleriano, J.S.,; Krein, C.;, Chaves, L.D.P. 2024. Acesso, regionalização e estratégias de gestão para avançar na eliminação das hepatites virais. Revista Brasileira De Gestão E Desenvolvimento Regional, 20(1)RBGDR. 2024;20(1): 688-713. Disponível em: https://doi.org/10.54399/rbgdr.v20i1.6954.
[18] Gleriano, J.S.;, Chaves, L.D.P.,; Krein, C.;, Henriques, S.H. 2022. Contribuições da avaliação para a gestão do SUS no enfrentamento das hepatites virais. CuidArte. Enfermagem.. 2022; 16(2): 176-187.
[19] Almeida, E.C.; Gleriano, J.S.; Pinto, F.K.A.; Coelho, R.A.; Vivaldini, S.M.; Gomes, J.N.N.; Santos, A.F.; Sereno, L.S.; Pereira, G.F.M.; Henriques, S.H.; Chaves, L.D.P. 2019. Almeida EC, Gleriano JS, Pinto FKA, Coelho RA, Vivaldini SM, Gomes JNN, et al. Acesso à atenção às hepatites virais: distribuição de serviços na região Norte do Brasil. Revista Brasileira de Epidemiologia. 2019; 22(SUPPL 1):: eE190008.supl.1. https://doi.org/10.1590/1980-549720190008.supl.1.
[20] Gleriano, J.S.;, Krein, C.;, Chaves, L.D.P. 2024. Aspects that facilitate access to care for viral hepatitis: An evaluative research. Sao Paulo Medical Journal. . 2024;142(4): e2023078. https://doi.org/10.1590/1516-3180.2023.0078.R1.29112023.
[21] Gleriano, J.S.;, Chaves, L.D.P.;, França, R.N.C.,; Ferreira, J.B.B.,; Forster, A.C. 2022. A pandemia da COVID-19 expõe crise de gestão no Sistema Único de Saúde? Saúde Redes. 2022;8(3): 537-554.
[22] Ministério da Saúde Brasil (BR). 2024. Decreto n.º 11.908, de 6 de fevereiro de 2024. Institui o Programa Brasil Saudável – Unir para Cuidar, e altera o Decreto nº 11.494, de 17 de abril de 2023, para dispor sobre o Comitê Interministerial para a Eliminação da Tuberculose e de Outras Doenças Determinadas Socialmente – CIEDDS. 2024. Ministério da Saúde, Brasília, DF. [citado 2025 jun 25]. Disponível em: https://www.planalto.gov.br/ccivil_03/_ato2023-2026/2024/decreto/D11908.htm. Acesso em 25 jun. 2025.
COMO CITAR
Gleriano, J.S.; Krein, C.; Chaves, L.D.P. Gestão em saúde e hepatites virais no Brasil: políticas e objetivos do desenvolvimento sustentável em perspectiva integrada. Revista E&S. 2025; 6: e2025023.
ABOUT THE AUTHORS
Josué Souza Gleriano – PhD in Fundamental Nursing from the University of São Paulo. Professor and researcher in the area of Health Policy, Planning, and Management. State University of Mato Grosso. Avenida Inácio Bittencourt Cardoso, 6967 E, Jardim Aeroporto, 78301-532, Tangará da Serra, Mato Grosso, Brazil.
Carlise Krein – Doctoral student in the Graduate Program in Fundamental Nursing by the University of São Paulo. School of Nursing of Ribeirão Preto, EERP/USP. Rua Professor Hélio Lourenço, 3900, Vila Monte Alegre, 14040-902, Ribeirão Preto, São Paulo, Brazil.
Lucieli Dias Pedreschi Chaves – PhD in Nursing from the University of São Paulo. Associate Professor by the Ribeirão Preto School of Nursing. Advisor of the Graduate Program in Fundamental Nursing. Ribeirão Preto School of Nursing, EERP/USP. Rua Professor Hélio Lourenço, 3900, Vila Monte Alegre, 14040-902 Ribeirão Preto, São Paulo, Brazil.